Literature DB >> 6138790

The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat.

D Clark, A Carlsson, S Hjorth, J Engel, P Lindberg.   

Abstract

The effects of the enantiomers of 3-PPP on the maintenance of conditioned avoidance responding (CAR) were studied. The weak classical dopamine (DA) agonist (+)-3-PPP failed to interfere with CAR at any dose tested (0.8-13.6 mg/kg). Low doses of the drug produced sedation, while high doses produced behavioural stimulation. (-)-3-PPP, which acts as an antagonist on postsynaptic and as an agonist on autoreceptor DA sites, reduced avoidance with no effect on escape behaviour (6.8-13.6 mg/kg). However, this reduction of CAR occurred at doses much higher than those previously demonstrated to inhibit locomotor activity. This profile is discussed in relation to the behavioural effects of classical postsynaptic DA receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138790     DOI: 10.1007/bf00439266

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  3 in total

1.  Drugs and the conditioned avoidance response.

Authors:  A HERZ
Journal:  Int Rev Neurobiol       Date:  1960       Impact factor: 3.230

2.  3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors.

Authors:  S Hjorth; A Carlsson; H Wikström; P Lindberg; D Sanchez; U Hacksell; L E Arvidsson; U Svensson; J L Nilsson
Journal:  Life Sci       Date:  1981-03-16       Impact factor: 5.037

3.  Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade.

Authors:  J Arnt
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-10
  3 in total
  10 in total

1.  Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.

Authors:  M L Wadenberg; S Ahlenius
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm.

Authors:  S Hjorth; A Carlsson; J A Engel
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 3.  Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.

Authors:  S Hjorth; K Svensson; A Carlsson; H Wikström; B Andersson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

5.  Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.

Authors:  S Hjorth; A Carlsson; D Clark; K Svensson; H Wikström; D Sanchez; P Lindberg; U Hacksell; L E Arvidsson; A Johansson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats.

Authors:  J Arnt; J Hyttel
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

7.  Effects of (-)3-PPP on acquisition and retention of a conditioned avoidance response in the rat.

Authors:  S Ahlenius; T Archer; B Tandberg; V Hillegaart
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Limited stimulus generalization between delta 9-THC and diazepam in pigeons and gerbils.

Authors:  T U Järbe; A J Hiltunen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system.

Authors:  D Clark; G Engberg; E Pileblad; T H Svensson; A Carlsson; A S Freeman; B S Bunney
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

10.  Dopamine agonists facilitate footshock-elicited locomotion in rats, and suppress level-press responding for food.

Authors:  S R Franklin; A H Tang
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.